Meta is heading into earnings with a big move expected [Yahoo! Finance]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
Health Canada has approved a generic version of semaglutide, the active ingredient behind Ozempic, with clearance going to Dr. Reddy's Laboratories. It's a notable moment because Canada becomes the first G7 country to allow a generic version of the drug. That said, the approval is limited to diabetes treatment and doesn't extend to the weight-loss use, where Novo markets the drug as Wegovy. Warning! GuruFocus has detected 2 Warning Sign with NVO. Is NVO fairly valued? Test your thesis with our free DCF calculator. Even so, this could be the start of a broader shift. Regulators said there are already 8 more applications under review, including from Teva Pharmaceutical Industries and Sandoz, which suggests more competition could follow over time.
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Canada approves generic version of Novo's Ozempic [Seeking Alpha]Seeking Alpha
- Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in CanadaBusiness Wire
- Health Canada approves 1st generic version of Ozempic in the country [BNN Bloomberg (Canada)]BNN Bloomberg
- Health Canada approves 1st generic version of Ozempic in the country [Yahoo! Finance Canada]Yahoo! Finance Canada
- Dr. Reddy's Laboratories (RDY) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c)" to "hold (c+)".MarketBeat
RDY
Earnings
- 1/22/26 - Beat
RDY
Sec Filings
- 4/29/26 - Form 6-K
- 4/24/26 - Form 6-K
- 4/24/26 - Form 6-K
- RDY's page on the SEC website